Anatomical and Functional Outcomes of Prolift Transvaginal Mesh for Treatment of Pelvic Organ Prolapse.
OBJECTIVE
To evaluate anatomical and functional outcomes of the Prolift Transvaginal Mesh for treatment of pelvic organ prolapse (POP) with regard to safety and satisfaction.


METHODS
We reviewed the medical records of 163 patients who underwent POP repair with Prolift Transvaginal Mesh between December 2005 and March 2012. An "optimal" anatomic outcome was defined as Pelvic Organ Prolapse Quantification System (POP-Q) stage 0, and a "satisfactory" anatomic outcome was defined as POP-Q stage 1.


RESULTS
A total of 163 patients were included in this study, with a mean age (range) of 61.6 (35-83) years. An anterior mesh was used in 110 patients, and combined anterior and posterior mesh was used in 53 patients. The mean follow-up period after POP repair was 40.4 (12-63) months. Optimal anatomic outcomes for anterior, apical, and posterior prolapse were achieved in 55.9, 69.2, and 65.8% of cases, respectively. Optimal or satisfactory anatomic outcomes for anterior, apical, and posterior prolapse occurred in 76.7, 85.0, and 82.5% of cases, respectively. Mean values for points in the POP-Q, urinary distress inventory (UDI), and pelvic organ prolapsed distress inventory (POPDI) in the Pelvic Floor Distress Inventory (PFDI) were all significantly improved after the operation. The overall satisfaction rate for the operation was 84.7%. Five patients (3.1%) were diagnosed with vaginal erosion and treated with partial excision of the mesh without evidence of infection.


CONCLUSIONS
Pelvic organ prolapse repair using Prolift Transvaginal Mesh is an effective and safe procedure without significant complications.
Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Wan
W
Song
Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Tae Heon
TH
Kim
Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Jin Woo
JW
Chung
Department of Urology, Chosun University Hospital, Chosun University School of Medicine, Gwangju, Korea.
Won Jin
WJ
Cho
Department of Urology, Ewha Womans University Medical Center, Seoul Seonam Hospital, Seoul, Korea.
Ha Na
HN
Lee
Department of Urology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
Young Suk
YS
Lee
Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. ksleedr@skku.edu.
Kyu-Sung
KS
Lee
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008875:Middle Aged; D061646:Operative Time; D017060:Patient Satisfaction; D056887:Pelvic Organ Prolapse / Q000503:physiopathology / Q000601:surgery*; D011182:Postoperative Care; D011300:Preoperative Care; D053825:Suburethral Slings; D013526:Surgical Mesh; D016896:Treatment Outcome; D014563:Urodynamics / Q000502:physiology
Prolift Transvaginal Mesh; pelvic organ prolapse; treatment outcome